THE EFFECT OF NOVEL COMPOUND MCC950 ON THE NLRP3 INFLAMMASOME IN THE RA JOINT

被引：2

作者：

McGarry, T. ^{[1
]}

Robertson, A. A. ^{[2
]}

Orr, C. ^{[1
]}

Coll, R. C. ^{[3
]}

Cooper, M. A. ^{[2
]}

O'Neill, L. A. ^{[3
]}

Veale, D. J. ^{[1
]}

Fearon, U. ^{[1
]}

机构：

[1] Univ Coll Dublin, Dublin Acad Med Ctr, Ctr Arthrit & Rheumat Dis, Dublin, Ireland

[2] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia

[3] Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷

关键词：

D O I：

10.1136/annrheumdis-2015-eular.3985

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

THU0027

引用

页码：202 / 202

页数：1

共 50 条

[31] Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease [J].

Ostergaard, Jakob A. ;

Jha, Jay C. ;

Sharma, Arpeeta ;

Dai, Aozhi ;

Choi, Judy S. Y. ;

de Haan, Judy B. ;

Cooper, Mark E. ;

Jandeleit-Dahm, Karin .

CLINICAL SCIENCE, 2022, 136 (02) :167-180

[32] MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions [J].

Zheng, Yujia ;

Zhang, Xiaolu ;

Wang, Ziyu ;

Zhang, Ruifeng ;

Wei, Huayuan ;

Yan, Xu ;

Jiang, Xijuan ;

Yang, Lin .

ARCHIV DER PHARMAZIE, 2024, 357 (11)

[33] Addendum: MCC950 closes the active conformation of NLRP3 to an inactive state [J].

Ana Tapia-Abellán ;

Diego Angosto-Bazarra ;

Helios Martínez-Banaclocha ;

Carlos de Torre-Minguela ;

Jose P. Cerón-Carrasco ;

Horacio Pérez-Sánchez ;

Juan I. Arostegui ;

Pablo Pelegrin .

Nature Chemical Biology, 2021, 17 :361-361

[34] A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation [J].

Zhang, CongXiao ;

Zhu, XinWang ;

Li, LuLu ;

Ma, TianKui ;

Shi, Mai ;

Yang, Ying ;

Fan, QiuLing .

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 :1297-1309

[35] MCC950 attenuates inflammation-mediated damage in canines with Staphylococcus pseudintermedius keratitis by inhibiting the NLRP3 inflammasome [J].

Guo, Long ;

Wang, Zhihao ;

Li, Jun ;

Cui, Luying ;

Dong, Junsheng ;

Meng, Xia ;

Zhu, Guoqiang ;

Li, Jianji ;

Wang, Heng .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 108

[36] MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice [J].

Perera, Agampodi Promoda ;

Fernando, Ruchira ;

Shinde, Tanvi ;

Gundamaraju, Rohit ;

Southam, Benjamin ;

Sohal, Sukhwinder Singh ;

Robertson, Avril A. B. ;

Schroder, Kate ;

Kunde, Dale ;

Eri, Rajaraman .

SCIENTIFIC REPORTS, 2018, 8

[37] Adenine model of chronic renal failure in rats to determine whether MCC950, an NLRP3 inflammasome inhibitor, is a renopreventive [J].

Mahmoud S. Sabra ;

Fahmy K. Hemida ;

Essmat A. H. Allam .

BMC Nephrology, 24

[38] MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats [J].

Zhao, Junjie ;

Guo, Xiaoye ;

Wang, Bo ;

Yang, Zhongbo ;

Huang, Tingqin ;

Guo, Dan ;

Zhang, Ming ;

Song, Jinning .

NEUROCHEMICAL RESEARCH, 2020, 45 (09) :2020-2031

[39] MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats [J].

Junjie Zhao ;

Xiaoye Guo ;

Bo Wang ;

Zhongbo Yang ;

Tingqin Huang ;

Dan Guo ;

Ming Zhang ;

Jinning Song .

Neurochemical Research, 2020, 45 :2020-2031

[40] Can the NLRP3 Inflammasome inhibitor MCC950 improve the engraftment of embryonic cardiomyocytes in a murine model of myocardial infarction? [J].

Carls, E. ;

Schiffer, M. ;

Niemann, P. ;

Fleischmann, B. K. ;

Bakhtiary, F. ;

Roell, W. .

ACTA PHYSIOLOGICA, 2022, 236 :591-593

← 1 2 3 4 5 →